| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $142.1M | +2.1% |
| Cost of Revenue | $70.6M | +9.9% |
| Gross Profit | $71.5M | -4.6% |
| R&D Expense | $20.7M | -16.1% |
| SG&A Expense | $42.1M | +9.7% |
| Operating Income | -$18.0M | -2097.4% |
| Pre-tax Income | -$16.3M | -581.1% |
| Income Tax | $5.1M | -33.5% |
| Net Income | -$21.4M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $63.1M | +29.3% |
| Accounts Receivable | $12.6M | -0.7% |
| Current Assets | $153.0M | +11.8% |
| Total Assets | $186.0M | +7.1% |
| Current Liabilities | $46.4M | +22.1% |
| Total Liabilities | $53.2M | +17.2% |
| Stockholders' Equity | $132.7M | +3.5% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $20.1M | -15.9% |
| Capital Expenditures | $17K | — |
| Investing Cash Flow | -$3.6M | +53.4% |
| Financing Cash Flow | -$2.7M | +87.6% |
| Free Cash Flow | $20.1M | -15.9% |
| -112.7% |
| EPS (Basic) | -$0.23 | -91.7% |
| EPS (Diluted) | -$0.23 | -91.7% |